Cargando…

Hyperviscosity Retinopathy and Immunogammopathy Maculopahy as New Onset of Multiple Myeloma

The purpose is to report a case of immunogammopathy maculopathy and hyperviscosity retinopathy as the presenting feature of new-onset multiple myeloma (MM) in an otherwise healthy man. A 50-years-old man presented with painless visual changes in both eyes for 2 months. Ocular examination revealed bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira Santos da Cruz, Natasha, Milhomens Filho, José Arthur Pinto, Ferraro, Desirée Mayara Nery, Polizelli, Murilo Ubukata, de Moraes Ambrogini, Nilva Simeren Bueno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299375/
https://www.ncbi.nlm.nih.gov/pubmed/34326757
http://dx.doi.org/10.1159/000514695
_version_ 1783726257294278656
author Ferreira Santos da Cruz, Natasha
Milhomens Filho, José Arthur Pinto
Ferraro, Desirée Mayara Nery
Polizelli, Murilo Ubukata
de Moraes Ambrogini, Nilva Simeren Bueno
author_facet Ferreira Santos da Cruz, Natasha
Milhomens Filho, José Arthur Pinto
Ferraro, Desirée Mayara Nery
Polizelli, Murilo Ubukata
de Moraes Ambrogini, Nilva Simeren Bueno
author_sort Ferreira Santos da Cruz, Natasha
collection PubMed
description The purpose is to report a case of immunogammopathy maculopathy and hyperviscosity retinopathy as the presenting feature of new-onset multiple myeloma (MM) in an otherwise healthy man. A 50-years-old man presented with painless visual changes in both eyes for 2 months. Ocular examination revealed bilateral CRVO-like associated with macular edema (ME) and an inferior serous detachment. Hematologic investigation revealed an increased percentage of plasma cells in the bone marrow, reaching the diagnosis of MM IgM/kappa. Clinical support and chemotherapy effectively improved ocular alterations, despite the residual ME. Injection of triamcinolone was carried out, without any response. Bilateral vision reduction with hyperviscosity syndrome-related retinopathy and immunogammopathy maculopathy was the first manifestation of an underlying systemic and potentially fatal disease. This case highlights the need for diligent and thorough investigations for less common systemic conditions associated with retinal vein occlusions.
format Online
Article
Text
id pubmed-8299375
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-82993752021-07-28 Hyperviscosity Retinopathy and Immunogammopathy Maculopahy as New Onset of Multiple Myeloma Ferreira Santos da Cruz, Natasha Milhomens Filho, José Arthur Pinto Ferraro, Desirée Mayara Nery Polizelli, Murilo Ubukata de Moraes Ambrogini, Nilva Simeren Bueno Case Rep Ophthalmol Case Report The purpose is to report a case of immunogammopathy maculopathy and hyperviscosity retinopathy as the presenting feature of new-onset multiple myeloma (MM) in an otherwise healthy man. A 50-years-old man presented with painless visual changes in both eyes for 2 months. Ocular examination revealed bilateral CRVO-like associated with macular edema (ME) and an inferior serous detachment. Hematologic investigation revealed an increased percentage of plasma cells in the bone marrow, reaching the diagnosis of MM IgM/kappa. Clinical support and chemotherapy effectively improved ocular alterations, despite the residual ME. Injection of triamcinolone was carried out, without any response. Bilateral vision reduction with hyperviscosity syndrome-related retinopathy and immunogammopathy maculopathy was the first manifestation of an underlying systemic and potentially fatal disease. This case highlights the need for diligent and thorough investigations for less common systemic conditions associated with retinal vein occlusions. S. Karger AG 2021-07-01 /pmc/articles/PMC8299375/ /pubmed/34326757 http://dx.doi.org/10.1159/000514695 Text en Copyright © 2021 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Ferreira Santos da Cruz, Natasha
Milhomens Filho, José Arthur Pinto
Ferraro, Desirée Mayara Nery
Polizelli, Murilo Ubukata
de Moraes Ambrogini, Nilva Simeren Bueno
Hyperviscosity Retinopathy and Immunogammopathy Maculopahy as New Onset of Multiple Myeloma
title Hyperviscosity Retinopathy and Immunogammopathy Maculopahy as New Onset of Multiple Myeloma
title_full Hyperviscosity Retinopathy and Immunogammopathy Maculopahy as New Onset of Multiple Myeloma
title_fullStr Hyperviscosity Retinopathy and Immunogammopathy Maculopahy as New Onset of Multiple Myeloma
title_full_unstemmed Hyperviscosity Retinopathy and Immunogammopathy Maculopahy as New Onset of Multiple Myeloma
title_short Hyperviscosity Retinopathy and Immunogammopathy Maculopahy as New Onset of Multiple Myeloma
title_sort hyperviscosity retinopathy and immunogammopathy maculopahy as new onset of multiple myeloma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299375/
https://www.ncbi.nlm.nih.gov/pubmed/34326757
http://dx.doi.org/10.1159/000514695
work_keys_str_mv AT ferreirasantosdacruznatasha hyperviscosityretinopathyandimmunogammopathymaculopahyasnewonsetofmultiplemyeloma
AT milhomensfilhojosearthurpinto hyperviscosityretinopathyandimmunogammopathymaculopahyasnewonsetofmultiplemyeloma
AT ferrarodesireemayaranery hyperviscosityretinopathyandimmunogammopathymaculopahyasnewonsetofmultiplemyeloma
AT polizellimuriloubukata hyperviscosityretinopathyandimmunogammopathymaculopahyasnewonsetofmultiplemyeloma
AT demoraesambrogininilvasimerenbueno hyperviscosityretinopathyandimmunogammopathymaculopahyasnewonsetofmultiplemyeloma